On 1 October 2026, I will begin a new chapter as Head of Medis. I am honored to join a business known for its pharmaceutical expertise, entrepreneurial spirit and trusted customer partnerships.

Although I have not officially started yet, I already see what makes Medis distinctive: the strength and capabilities of Teva, combined with the agility and personal attention of a focused global out-licensing partner.

As I prepare to step into the role, I would like to share what brought me here and what I hope we can build together.

Bringing strategy and execution together

I have spent 19 years at Teva—16 of them in Global Operations, leading manufacturing and supply chain organizations, network strategy and major transformation programs. Over the past three years, I have worked in Teva’s Strategy & Transformation Office on growth, modernization and business acceleration.

That journey has shaped how I lead. Strategy matters, but it creates value only when teams set clear priorities, work across boundaries and execute with discipline. The real test is whether we deliver better, more consistent outcomes for customers.

This is what attracted me to Medis: a business that combines deep expertise with speed, flexibility and a clear commitment to helping partners grow.

What attracted me to Medis

Medis is more than a source of products. Its commercial, portfolio, supply chain, regulatory, quality and customer-experience teams support partners across the full journey—from opportunity to reliable delivery.

Behind those capabilities is an experienced global team that understands that every customer, portfolio and market is different. That ability to be global and personal, structured and flexible, is a real strength—and one I want us to protect and build on.

My first priority is to listen

My first priority is simple: to listen. I want to meet our customers and partners, understand their businesses and hear directly what Medis does well, where we can improve and where we can create more value together.

For me, true partnership starts with curiosity and open communication. It grows through transparency, reliability and a willingness to solve challenges together—especially when circumstances are complex.

People at the center

I believe people are at the center of every successful strategy and every strong partnership. Processes and systems are essential, but people bring them to life.

My role is to create clarity, empower teams to take ownership and make it easier to collaborate across functions. When our people understand customer priorities and feel trusted to act, we can respond faster and deliver better outcomes.

Customers will continue working with the dedicated teams and contacts they know and trust. The responsiveness, flexibility and personal attention that define Medis will remain central to how we operate, while we keep improving how consistently we deliver.

My vision for the future of Medis

My ambition is clear: to strengthen Medis as a trusted global pharmaceutical out-licensing partner by focusing on what creates lasting value:

• Listen closely and anticipate changing customer needs
• Build reliable, long-term partnerships based on trust
• Connect customers to the strength of Teva’s portfolio and capabilities
• Turn opportunities into sustainable value through strong execution

Our future will be defined not only by the products we offer, but also by how we work, communicate and deliver on our commitments.

Looking ahead together

I am genuinely excited about what lies ahead. Medis has a strong global team, lasting partnerships and significant opportunities to grow.

In the coming months, I look forward to meeting many of you, learning about your priorities and exploring how Medis can support your portfolio and market ambitions.

Thank you for your trust and partnership. I look forward to building the next chapter of Medis together.

Hadas Azulai
VP, Head of Medis